Financial Performance - The company's revenue for the first quarter reached ¥322,200,052.44, representing a year-on-year increase of 22.60% compared to ¥262,803,224.93[4] - Net profit attributable to shareholders was ¥16,375,863.17, a significant turnaround from a loss of ¥10,909,451.92 in the same period last year, marking a 250.11% increase[4] - The basic earnings per share increased to ¥0.10 from a loss of ¥0.07, reflecting a growth of 242.86%[4] - The diluted earnings per share also improved to ¥0.09 from a loss of ¥0.07, showing a 228.57% increase[5] - The weighted average return on equity rose to 1.03%, an increase of 1.73 percentage points compared to -0.70% in the previous year[5] - The net profit for Q1 2025 was CNY 15,380,038.91, a significant recovery from a net loss of CNY 11,649,422.29 in Q1 2024, marking a turnaround in performance[22] - Operating profit for the period was CNY 16,335,392.15, compared to an operating loss of CNY 16,307,021.90 in the same quarter last year[21] - The total comprehensive income for the period was CNY 15,380,038.91, contrasting with a total comprehensive loss of CNY -25,147,778.06 in the same quarter last year[22] Cash Flow and Operating Activities - The net cash flow from operating activities was negative at -¥78,629,355.18, worsening from -¥66,219,658.39 year-on-year, a decline of 18.74%[4] - The company reported a net cash outflow from operating activities of CNY -78,629,355.18, worsening from CNY -66,219,658.39 in Q1 2024[25] - Investment activities generated a net cash inflow of CNY 21,093,038.64, a decrease from CNY 72,663,039.38 in the previous year[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,780,508,415.67, a slight increase of 1.28% from ¥2,745,232,212.30 at the end of the previous year[5] - Current assets totaled RMB 1,596,224,573.62 as of March 31, 2025, compared to RMB 1,544,491,817.38 at the end of 2024, showing an increase of 3.3%[15] - Total liabilities were RMB 1,193,364,399.68 as of March 31, 2025, compared to RMB 1,174,190,825.27 at the end of 2024, indicating an increase of 1.6%[16] - Shareholders' equity totaled RMB 1,587,144,015.99 as of March 31, 2025, compared to RMB 1,571,041,387.03 at the end of 2024, representing a growth of 1.0%[17] Operating Costs and Expenses - Total operating costs for Q1 2025 were RMB 304,631,137.53, up from RMB 273,291,745.76 in Q1 2024, reflecting a growth of 11.5%[20] - Operating costs included RMB 273,689,998.82 in operating expenses for Q1 2025, compared to RMB 243,706,743.19 in Q1 2024, indicating a rise of 12.3%[20] - The company incurred research and development expenses of CNY 10,192,622.79, an increase from CNY 9,253,218.37 in the previous year, reflecting a focus on innovation[21] - Financial expenses included interest expenses of CNY 1,955,606.08, slightly up from CNY 1,872,472.48 in Q1 2024[21] Inventory and Cash Management - Cash and cash equivalents were RMB 557,380,441.70 as of March 31, 2025, down from RMB 575,009,309.85 at the end of 2024, a decrease of 3.0%[14] - Inventory increased to RMB 243,128,515.76 as of March 31, 2025, compared to RMB 231,412,437.26 at the end of 2024, marking a rise of 5.0%[15] - Cash and cash equivalents at the end of Q1 2025 stood at CNY 482,465,747.03, down from CNY 701,706,964.69 at the end of Q1 2024[26] Non-recurring Gains and Losses - Non-recurring gains and losses amounted to ¥1,807,181.73 after tax, with significant contributions from government subsidies and other income[7] - The company reported a significant increase in sales volume and price for key products, driving the growth in net profit and earnings per share[9]

Financial Performance - The net profit attributable to shareholders of Jiangsu Fengshan Group Co., Ltd. for the year 2024 was -38,625,401.12 RMB, showing a slight improvement of 1.36% compared to -39,159,426.56 RMB in 2023[6]. - The total operating revenue for 2024 was 1,043,719,124.23 RMB, a decrease of 12.76% from 1,196,373,565.89 RMB in 2023[24]. - The net cash flow from operating activities increased significantly by 123.37% to 155,838,907.40 RMB compared to 69,767,520.07 RMB in 2023[25]. - The total assets of the company as of the end of 2024 were 2,745,232,212.30 RMB, reflecting a 2.00% increase from 2,691,417,463.41 RMB at the end of 2023[25]. - The net assets attributable to shareholders of the company increased by 1.03% to 1,574,297,599.36 RMB compared to 1,558,235,015.21 RMB in 2023[25]. - Basic earnings per share for 2024 is -0.23 yuan, a 2.17% improvement compared to -0.24 yuan in 2023[26]. - The company reported a net cash flow from operating activities of 168,451,141.42 yuan in Q4 2024, indicating a significant recovery[28]. - Non-recurring gains and losses for 2024 totaled -2,851,502.91 yuan, with government subsidies contributing 5,093,451.83 yuan[29]. - Operating profit was reported at CNY -34,185,100, an improvement of 17.19% from the previous year's loss of CNY -41,279,400[63]. - The company's main business revenue decreased by 12.96% to CNY 1,039,093,000, primarily due to a downturn in the pesticide industry and significant price declines[65]. Shareholder Returns - The company will not distribute profits or conduct capital reserve transfers for the year 2024 due to the negative net profit[6]. - The company has outlined a three-year shareholder return plan for 2024-2026, which includes conditions for cash dividends based on positive distributable profits[6]. - The profit distribution plan for 2024 is to not distribute profits or increase capital reserves, which has been approved by the board[198]. - Due to the negative net profit, the company does not meet the conditions for cash dividends in 2024[198]. - The cash dividend policy complies with the company's articles of association and shareholder resolutions[199]. Risk Management - The company has provided a detailed risk statement regarding potential future risks in its management discussion and analysis section[9]. - The company recognizes risks related to environmental regulations and will continue to prioritize safety and environmental management to ensure stable operations[155]. - The company faces risks from raw material supply and price fluctuations, which could impact production and operational efficiency, and plans to enhance procurement strategies[156]. - The company will strengthen its international trade strategies to mitigate risks associated with export policies and currency fluctuations[159]. - The company faces risks related to fundraising projects not meeting expectations due to potential price increases in basic chemical products, which are the main raw materials for these projects[160]. Market and Product Development - The company is focusing on product quality and brand strength in the pesticide sector, emphasizing technological innovation and new product development[34]. - The company is advancing the development of new battery electrolyte products, including fast-charging and semi-solid battery electrolytes, to meet the needs of major clients in the industry[41]. - The company plans to enhance market development capabilities through technological innovation and collaborative research[35]. - The agricultural pesticide sector is experiencing a recovery in market demand since 2024, despite being in a price consolidation phase[47]. - The company is focusing on integrated development in the pesticide sector, enhancing its competitive advantage through a comprehensive approach to raw materials and formulations[134]. Corporate Governance - The company has established a governance structure that includes a board of directors, supervisory board, and senior management, ensuring clear responsibilities and regulatory compliance[165]. - The board consists of 8 members, including 3 independent directors, and operates through specialized committees to provide scientific and professional advice[166]. - The company has implemented measures to enhance investor relations and communication, including hosting quarterly online performance briefings[167]. - The company adheres to strict information disclosure regulations, with the chairman and board secretary responsible for ensuring transparency[167]. - The company has not identified any significant discrepancies between its governance practices and regulatory requirements[168]. Research and Development - The company has established several R&D platforms, including the Jiangsu Provincial Enterprise Technology Center and the Jiangsu (Fengshan) Chiral Pesticide Engineering Technology Center, to enhance its innovation capabilities[61]. - The company has received recognition as a high-tech enterprise as of 2024, with a total of 25 authorized invention patents and 2 utility model patents[61]. - The company has a strong focus on expanding its market presence through strategic partnerships and collaborations[177]. - The company is actively involved in research and development of new products and technologies to enhance its competitive edge[177]. - The company emphasizes the importance of sustainability and environmental responsibility in its business practices[177]. Operational Efficiency - The company aims to enhance operational efficiency and reduce costs by optimizing organizational structure and management levels, focusing on lean management across all value chains[39]. - The overall cost structure improved, with a significant reduction in environmental disposal fees and steam prices contributing to lower total costs[73]. - The company has implemented a performance evaluation system that emphasizes actual work efficiency and resource optimization to enhance productivity[39]. - The company plans to focus on pesticide products in 2024, with subsidiaries involved in electronic products and agricultural production[68]. - The company is committed to developing a full industrial chain of high-end fine chemicals, particularly focusing on toluene chlorination and fluorination, while exploring mergers and acquisitions to enhance market competitiveness[148].

江苏丰山集团股份有限公司 董事会审计委员会工作细则 第一章 总则 第一条 为规范公司董事会审议委员会（以下简称"审计委员会"）的议事 程序，公司董事会根据《中华人民共和国公司法》（以下简称"《公司法》"）、《 上市公司治理准则》《上市公司独立董事管理办法》《上海证券交易所股票上市 规则》等有关法律法规和规范性文件及《江苏丰山集团股份有限公司章程》（以 下简称"《公司章程》"）的有关规定，制定本工作细则。 第二条 审计委员会是董事会下设的专门委员会，对董事会负责。审计委员 会主要负责审核公司财务信息及其披露、监督及评估内外部审计工作和内部控 制。 第二章 人员组成 第三条 审计委员会由三名不在公司担任高级管理人员的董事组成，其中独 立董事过半数且至少有一名独立董事为会计专业人士。由独立董事中会计专业 人士担任召集人。 前款所称会计专业人士应具备较丰富的会计专业知识和经验，并至少符合 下列条件之一： （一）具有注册会计师执业资格； （二）具有会计、审计或者财务管理专业的高级职称、副教授职称或者博 士学位； （三）具有经济管理方面高级职称，且在会计、审计或者财务管理等专业 岗位有5年以上全职工作经验。 第四条 审计 ...

江苏丰山集团股份有限公司 2024 年度独立董事述职报告 作为江苏丰山集团股份有限公司（以下简称"公司"）的独立董事，2024 年 度任职期间，本人积极参加交易所组织的学习培训，努力提高独立董事的履职水 平，严格按照《公司法》《上海证券交易所股票上市规则》《上海证券交易所上 市公司自律监管指引第 1 号—规范运作》《上市公司独立董事管理办法》等相关 法律法规的要求，勤勉尽责地履行独立董事的职责与义务，审慎行使公司和股东 所赋予的权利，积极出席董事会或股东大会等相关会议，认真审议董事会各项议 案，对重大事项发表了公正、客观的独立意见，充分发挥了独立董事的作用。不 受公司大股东、实际控制人或者其他与公司存在利害关系的单位或个人的影响， 维护了公司整体利益及中小股东的合法权益。现将 2024 年度履行职责情况汇报 如下： 一、独立董事的基本情况 本人经公司于 2024 年 5 月 20 日召开的 2024 年年度股东大会选举，担任公 司第四届董事会独立董事。2024 年度任职期间，作为独立董事，本人拥有专业 资质及能力，在从事的专业领域积累了丰富的经验，对公司董事会审议的议案， 从客观、公正的立场出发，做出独立判断 ...

江苏丰山集团股份有限公司 董事会议事规则 第一章 总则 第一条 为规范江苏丰山集团股份有限公司（以下简称公司）董事会的议事 方式和决策程序，保证董事会依法行使职权，根据《中华人民共和国公司法》（ 以下简称《公司法》）《中华人民共和国证券法》《上市公司治理准则》《上海证 券交易所股票上市规则》（以下简称《上市规则》）等法律法规和规范性文件及 《江苏丰山集团股份有限公司章程》（以下简称《公司章程》）等有关规定，制 定本规则。 第二条 董事会对股东会负责，执行股东会决议，在法律法规及《公司章程》 和股东会赋予的职权范围内行使职权，维护公司及股东的合法权益。 第三条 董事会秘书负责董事会日常事务，保管董事会印章。董事会秘书可 以指定证券事务代表等有关人员协助其处理日常事务。 第二章 董事会会议的召集与通知 第四条 董事会会议分为定期会议和临时会议。定期会议每年至少召开两次。 有下列情形之一的，董事会应当召开临时会议： 1 （一）代表十分之一以上表决权的股东提议时； （二）三分之一以上董事联名提议时； （三）审计委员会提议时； （四）董事长认为必要时； （五）独立董事提议并经全体独立董事过半数同意时； （六）总裁提议时 ...

江苏丰山集团股份有限公司 2024 年度独立董事述职报告 作为江苏丰山集团股份有限公司（以下简称"公司"）的独立董事，2024 年 度积极参加交易所组织的学习培训，努力提高独立董事的履职水平。2024 年度 本人严格按照《公司法》《上海证券交易所股票上市规则》《上海证券交易所上 市公司自律监管指引第 1 号—规范运作》《上市公司独立董事管理办法》等相关 法律法规的要求，勤勉尽责地履行独立董事的职责与义务，审慎行使公司和股东 所赋予的权利，积极出席董事会或股东大会等相关会议，认真审议董事会各项议 案，充分发挥了独立董事的作用。不受公司大股东、实际控制人或者其他与公司 存在利害关系的单位或个人的影响，维护了公司整体利益及中小股东的合法权益。 现将 2024 年度履行职责情况汇报如下： 一、独立董事的基本情况 本人经公司于 2023 年 12 月 6 日召开的 2023 年第二次临时股东大会选举， 继续担任公司第四届董事会独立董事，作为独立董事，本人拥有专业资质及能力， 在从事的专业领域积累了丰富的经验，对公司董事会审议的议案，从客观、公正 的立场出发，做出独立判断。自任职以来，本人及本人直系亲属、主要社会关系 不 ...

| | | 江苏丰山集团股份有限公司 章 程 | | | 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。公司 系由江苏丰山集团有限公司以整体变更的方式发起设立的股份有限公司，在江苏 省盐城市市场监督管理局注册登记，取得营业执照，营业执照统一社会信用代码： 9132090013485559XP。 第三条 公司于 2018 年 8 月 31 日经中国证券监督管理委员会（以下简称" 中国证监会"）核准，首次向社会公众发行人民币普通股 2,000 万股，并于 2018 年 9 月 17 日在上海证券交易所上市。 第一章 总则 第一条 为维护江苏丰山集团股份有限公司（以下简称"公司"）、股东、 职工和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司 法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称《证 券法》）和其他有关规定，制定本章程。 第六条 公司注册资本为人民币 165,245,996 元。 第七条 公司为永久存续的股份有限公司。 第八条 董事长为公司的法定代表人。董事辞任董事长职务的，视为同时辞 去法定代表人。法定代表人辞任的，公司将在法定代表人辞任之日起三十日 ...

江苏丰山集团股份有限公司 会计师事务所选聘制度 第一章 总则 第一条 为规范江苏丰山集团股份有限公司（以下简称"公司"）选聘（含 续聘、改聘）会计师事务所的行为，切实维护股东利益，提高财务信息的质量 ，根据《中华人民共和国公司法》《中华人民共和国证券法》《国有企业、上 市公司选聘会计师事务所管理办法》《上海证券交易所股票上市规则》等有关 法律法规、规范性文件及《公司章程》的相关规定，结合公司实际情况，制定 本制度。 第二条 本制度所称选聘会计师事务所，是指公司根据相关法律法规要求， 聘任会计师事务所对公司财务会计报告及内部控制发表审计意见、出具审计报 告的行为。 公司聘任会计师事务所从事除财务会计报告审计及内部控制审计之外的其 他法定审计业务的，按照公司其他相关制度组织实施。 第三条 公司选聘或解聘会计师事务所，应当由董事会审计委员会（以下简 称"审计委员会"）审议同意后，提交董事会审议，并由股东会决定。公司不 得在董事会及股东会审议批准前聘请会计师事务所开展审计业务。 第四条 公司控股股东、实际控制人不得在公司董事会及股东会审议前，向 公司指定会计师事务所，不得干预审计委员会独立履行审核职责。 第二章 会计 ...

第一章 总则 江苏丰山集团股份有限公司 董事会秘书工作细则 第一条 为保证江苏丰山集团股份有限公司（以下简称"公司"）董事会秘 书依法行使职权，认真履行工作职责，充分发挥董事会秘书在公司中的作用， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所 股票上市规则》等相关法律法规和规范性文件的有关规定及《江苏丰山集团股 份有限公司章程》（以下简称"《公司章程》"）的规定，制定本工作细则。 第二条 公司设董事会秘书一名。董事会秘书作为公司高级管理人员，为履 行职责有权参加相关会议，查阅有关文件，了解公司的财务和经营等情况。董 事会及其他高级管理人员应当支持董事会秘书的工作。任何机构及个人不得干 预董事会秘书的正常履职行为。 第三条 董事会秘书为公司与上海证券交易所之间的指定联络人。董事会秘 书或代行董事会秘书职责的人员有权以公司名义办理信息披露、公司治理、股 权管理等其相关职责范围内的事务。 第四条 公司设证券部，协助董事会秘书履行职责。董事会秘书负责管理证 券部工作。 第二章 任职资格 第五条 董事会秘书应当具备履行职责所必需的财务、管理、法律专业知识， 具有良好的职业道德和个人品德，董事会秘 ...

江苏丰山集团股份有限公司 2024 年度独立董事述职报告 我作为江苏丰山集团股份有限公司（以下简称"公司"）的独立董事，2024 年度积极参加交易所组织的学习培训，努力提高独立董事的履职水平。2024 年 度本人严格按照《公司法》《上海证券交易所股票上市规则》《上海证券交易所 上市公司自律监管指引第 1 号—规范运作》《上市公司独立董事管理办法》等相 关法律法规的要求，勤勉尽责地履行独立董事的职责与义务，审慎行使公司和股 东所赋予的权利，积极出席董事会或股东大会等相关会议，认真审议董事会各项 议案，对重大事项发表了公正、客观的独立意见，充分发挥了独立董事的作用。 不受公司大股东、实际控制人或者其他与公司存在利害关系的单位或个人的影响， 维护了公司整体利益及中小股东的合法权益。现将 2024 年度履行职责情况汇报 如下： （一）参加会议情况 1、出席董事会和股东大会的情况 任职期内，本人本着勤勉尽责的态度，积极参加公司召开的董事会。在任职 期间，对会议审议的议案及相关资料均认真审阅，与公司经营管理层保持了充分 的沟通，并提出合理化建议，为董事会科学决策发挥了积极的作用。2024 年度 任职期间，对公司董事会各项 ...